Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model

por Banevicius, Mary A, Kaplan, Nachum, Hafkin, Barry, Nicolau, David P
Publicado 2013

In vitro activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics

por Kaplan, Nachum, Awrey, Donald, Bardouniotis, Elias, Berman, Judd, Yethon, Jeremy, Pauls, Henry W, Hafkin, Barry
Publicado 2013